← Leaderboards
Dana Larocca
Ocata Therapeutics, Inc.
$2,270,692
Attributed
$2,270,692
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $582.5K · FY2008–18$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,270,692 · 9
By mechanism
R43$2,270,692 · 9
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsCell TypeBaseProgenitorSourcePluripotent Stem CellsCell LineStem CellsSelf-RenewalReagentHuman Embryonic Stem CellEmbryoLibrariesPhage DisplayPeptidesInjuryCell TherapyCell SeparationProductionQuantum DotsDegenerative DisorderBinding (Molecular Function)Public Health RelevanceSkin
Grant awards (11)
Metabolically Reprogrammed Mesenchymal Stem Cells for Treating Osteoporosis$224,973
R43 · FY2018 · AR · contact PI
Cell Targeting Peptides for Isolating Patient Specific Stem Cells$224,911
R43 · FY2014 · GM · contact PI
Rapid Multiplexed Nanoprobe Assays for Pluripotent Stem Cell Differentiation$292,261
R43 · FY2013 · GM · contact PI
Reagents for Targeted Ablation of Residual Contaminating Pluripotent Stem Cells$270,262
R43 · FY2013 · GM · contact PI
Reagents for Targeted Ablation of Residual Contaminating Pluripotent Stem Cells$12,495
R43 · FY2013 · GM · contact PI
Rapid Multiplexed Nanoprobe Assays for Pluripotent Stem Cell Differentiation$7,440
R43 · FY2013 · GM · contact PI
Functional Selection of Novel Ligands from the Neuroendocrine Secretome$239,316
R43 · FY2010 · DK · contact PI
Antibodies Targeting Novel Surface Antigens on Pluripotent Stem Cell Derivatives$325,822
R43 · FY2009 · GM · contact PI
Double-Gated Selection of Ligands that Target Surface Markers of Differentiation$241,141
R43 · FY2009 · HD · contact PI
New Tools for Identifying, Tracking, and Isolating Human Progenitor Cells$232,539
R43 · FY2008 · GM · contact PI
Defining Therapeutic Potential of Clonal Stem Cell Populations using Targeted Nan$199,532
R43 · FY2008 · GM · contact PI